佰仁医疗收盘上涨6.11%，滚动市盈率93.70倍，总市值159.77亿元

Group 1 - The core viewpoint of the news is that Baijun Medical's stock has seen a significant increase, closing at 115.99 yuan, up 6.11%, with a rolling PE ratio of 93.70, marking a new low in 69 days, and a total market capitalization of 15.977 billion yuan [1] - The average PE ratio for the medical device industry is 54.32, with a median of 38.11, placing Baijun Medical at the 104th position in the industry ranking [1] - As of the first quarter of 2025, 12 institutions hold shares in Baijun Medical, all of which are funds, with a total holding of 2.197 million shares valued at 226 million yuan [1] Group 2 - Baijun Medical specializes in the research, production, sales, and service of medical devices, with key products including biological patches for cardiac and thoracic surgery, artificial heart valves, and other surgical implant medical devices [1] - The latest performance report for the first quarter of 2025 shows that the company achieved a revenue of 100 million yuan, a year-on-year increase of 31.30%, and a net profit of 32.5043 million yuan, a year-on-year increase of 290.69%, with a gross profit margin of 85.72% [1] - The PE ratios of other companies in the medical device industry range from 10.99 to 20.27, with Baijun Medical having the highest PE ratio at 93.70 [2]